51 results
Page 2 of 3
6-K
EX-1.1
es9fyfgx1v7dc2 qc
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
6edl 8a99pp3
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
48l4gxe50l7g024
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
1kbsc
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
yvolw7 u9tf0pp
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
1wc99okm13xndy2
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
l834n2l93t5gdvuy
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
8sf41gke3 41
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
33fo3sjqoc 2y
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
64r5hkleaug2k7f74g5t
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
c26ez4w7bxp7e
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
ik7cgg9r1w73x90s2w
10 Jul 19
Prospectus supplement
8:18am
F-3
wesxhao oyy29zhq2
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
z6qx77mzbqjd1y02enuu
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
a7ex54iqust5q5
27 Mar 19
Securities Purchase Agreement
8:32am